Hashimoto's thyroiditis, or chronic lymphocytic thyroiditis, an autoimmune disorder targeting the thyroid gland, presents a global health concern. This review compiles current knowledge, advancements in research findings, and emerging trends related to this condition's etiopathogenesis, diagnosis, management, and complications. The intricate interplay of genetic predisposition, environmental triggers, and immunological mechanisms underscores the development of Hashimoto's thyroiditis. Novel insights into the genetic landscape and immune dysregulation pathways contribute to a deeper understanding of disease susceptibility and progression. Diagnostic advancements, including hormonal estimation, serological tests, ultrasound, and molecular imaging modalities, are pivotal in early detection and prognosis.Furthermore, the review delineates the heterogeneous clinical manifestations and challenges in managing the diverse symptomatology, emphasizing the necessity for personalized and tailored therapeutic approaches. The spectrum of treatment modalities spans conventional hormone replacement therapy to evolving interventions targeting immune modulation and personalized medicine. Lifestyle modifications and nutritional interventions also merit attention in optimizing patient outcomes. This review aims to furnish a comprehensive resource for clinicians, researchers, and healthcare stakeholders, fostering a nuanced understanding of Hashimoto's thyroiditis. This review seeks to inspire further investigations and innovative approaches towards improving patient care and outcomes by elucidating current trends and potential future directions.